TY - JOUR T1 - British Gynaecological Cancer Society recommendations for women with gynecological cancer who received non-standard care during the COVID-19 pandemic JF - International Journal of Gynecologic Cancer JO - Int J Gynecol Cancer SP - 9 LP - 14 DO - 10.1136/ijgc-2021-002942 VL - 32 IS - 1 AU - Alexandra Taylor AU - Sudha S Sundar AU - Rebecca Bowen AU - Rick Clayton AU - Sarah Coleridge AU - Christina Fotopoulou AU - Sadaf Ghaem-Maghami AU - Jonathan Ledermann AU - Ranjit Manchanda AU - Hilary Maxwell AU - Agnieszka Michael AU - Tracie Miles AU - Shibani Nicum AU - Andrew Nordin AU - Bruce Ramsay AU - Stuart Rundle AU - Sarah Williams AU - Nicholas J Wood AU - Dennis Yiannakis AU - Jo Morrison Y1 - 2022/01/01 UR - http://ijgc.bmj.com/content/32/1/9.abstract N2 - During the COVID-19 pandemic, pressures on clinical services required adaptation to how care was prioritised and delivered for women with gynecological cancer. This document discusses potential ‘salvage’ measures when treatment has deviated from the usual standard of care. The British Gynaecological Cancer Society convened a multidisciplinary working group to develop recommendations for the onward management and follow-up of women with gynecological cancer who have been impacted by a change in treatment during the pandemic. These recommendations are presented for each tumor type and for healthcare systems, and the impact on gynecological services are discussed. It will be important that patient concerns about the impact of COVID-19 on their cancer pathway are acknowledged and addressed for their ongoing care. ER -